178 related articles for article (PubMed ID: 30815012)
1. CircRNAs Are Here to Stay: A Perspective on the
Dal Molin A; Bresolin S; Gaffo E; Tretti C; Boldrin E; Meyer LH; Guglielmelli P; Vannucchi AM; Te Kronnie G; Bortoluzzi S
Front Genet; 2019; 10():88. PubMed ID: 30815012
[TBL] [Abstract][Full Text] [Related]
2. Circular RNAs drive oncogenic chromosomal translocations within the MLL recombinome in leukemia.
Conn VM; Gabryelska M; Toubia J; Kirk K; Gantley L; Powell JA; Cildir G; Marri S; Liu R; Stringer BW; Townley S; Webb ST; Lin H; Samaraweera SE; Bailey S; Moore AS; Maybury M; Liu D; Colella AD; Chataway T; Wallington-Gates CT; Walters L; Sibbons J; Selth LA; Tergaonkar V; D'Andrea RJ; Pitson SM; Goodall GJ; Conn SJ
Cancer Cell; 2023 Jul; 41(7):1309-1326.e10. PubMed ID: 37295428
[TBL] [Abstract][Full Text] [Related]
3. Discovery of fusion circular RNAs in leukemia with KMT2A::AFF1 rearrangements by the new software CircFusion.
Dal Molin A; Tretti Parenzan C; Gaffo E; Borin C; Boldrin E; Meyer LH; Te Kronnie G; Bresolin S; Bortoluzzi S
Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36585787
[TBL] [Abstract][Full Text] [Related]
4. circRNA circAF4 functions as an oncogene to regulate MLL-AF4 fusion protein expression and inhibit MLL leukemia progression.
Huang W; Fang K; Chen TQ; Zeng ZC; Sun YM; Han C; Sun LY; Chen ZH; Yang QQ; Pan Q; Luo XQ; Wang WT; Chen YQ
J Hematol Oncol; 2019 Oct; 12(1):103. PubMed ID: 31623653
[TBL] [Abstract][Full Text] [Related]
5. Bioflavonoids promote stable translocations between MLL-AF9 breakpoint cluster regions independent of normal chromosomal context: Model system to screen environmental risks.
Bariar B; Vestal CG; Deem B; Goodenow D; Ughetta M; Engledove RW; Sahyouni M; Richardson C
Environ Mol Mutagen; 2019 Mar; 60(2):154-167. PubMed ID: 30387535
[TBL] [Abstract][Full Text] [Related]
6. The MLL recombinome of acute leukemias in 2013.
Meyer C; Hofmann J; Burmeister T; Gröger D; Park TS; Emerenciano M; Pombo de Oliveira M; Renneville A; Villarese P; Macintyre E; Cavé H; Clappier E; Mass-Malo K; Zuna J; Trka J; De Braekeleer E; De Braekeleer M; Oh SH; Tsaur G; Fechina L; van der Velden VH; van Dongen JJ; Delabesse E; Binato R; Silva ML; Kustanovich A; Aleinikova O; Harris MH; Lund-Aho T; Juvonen V; Heidenreich O; Vormoor J; Choi WW; Jarosova M; Kolenova A; Bueno C; Menendez P; Wehner S; Eckert C; Talmant P; Tondeur S; Lippert E; Launay E; Henry C; Ballerini P; Lapillone H; Callanan MB; Cayuela JM; Herbaux C; Cazzaniga G; Kakadiya PM; Bohlander S; Ahlmann M; Choi JR; Gameiro P; Lee DS; Krauter J; Cornillet-Lefebvre P; Te Kronnie G; Schäfer BW; Kubetzko S; Alonso CN; zur Stadt U; Sutton R; Venn NC; Izraeli S; Trakhtenbrot L; Madsen HO; Archer P; Hancock J; Cerveira N; Teixeira MR; Lo Nigro L; Möricke A; Stanulla M; Schrappe M; Sedék L; Szczepański T; Zwaan CM; Coenen EA; van den Heuvel-Eibrink MM; Strehl S; Dworzak M; Panzer-Grümayer R; Dingermann T; Klingebiel T; Marschalek R
Leukemia; 2013 Nov; 27(11):2165-76. PubMed ID: 23628958
[TBL] [Abstract][Full Text] [Related]
7. The MLL recombinome of acute leukemias in 2017.
Meyer C; Burmeister T; Gröger D; Tsaur G; Fechina L; Renneville A; Sutton R; Venn NC; Emerenciano M; Pombo-de-Oliveira MS; Barbieri Blunck C; Almeida Lopes B; Zuna J; Trka J; Ballerini P; Lapillonne H; De Braekeleer M; Cazzaniga G; Corral Abascal L; van der Velden VHJ; Delabesse E; Park TS; Oh SH; Silva MLM; Lund-Aho T; Juvonen V; Moore AS; Heidenreich O; Vormoor J; Zerkalenkova E; Olshanskaya Y; Bueno C; Menendez P; Teigler-Schlegel A; Zur Stadt U; Lentes J; Göhring G; Kustanovich A; Aleinikova O; Schäfer BW; Kubetzko S; Madsen HO; Gruhn B; Duarte X; Gameiro P; Lippert E; Bidet A; Cayuela JM; Clappier E; Alonso CN; Zwaan CM; van den Heuvel-Eibrink MM; Izraeli S; Trakhtenbrot L; Archer P; Hancock J; Möricke A; Alten J; Schrappe M; Stanulla M; Strehl S; Attarbaschi A; Dworzak M; Haas OA; Panzer-Grümayer R; Sedék L; Szczepański T; Caye A; Suarez L; Cavé H; Marschalek R
Leukemia; 2018 Feb; 32(2):273-284. PubMed ID: 28701730
[TBL] [Abstract][Full Text] [Related]
8. New insights to the MLL recombinome of acute leukemias.
Meyer C; Kowarz E; Hofmann J; Renneville A; Zuna J; Trka J; Ben Abdelali R; Macintyre E; De Braekeleer E; De Braekeleer M; Delabesse E; de Oliveira MP; Cavé H; Clappier E; van Dongen JJ; Balgobind BV; van den Heuvel-Eibrink MM; Beverloo HB; Panzer-Grümayer R; Teigler-Schlegel A; Harbott J; Kjeldsen E; Schnittger S; Koehl U; Gruhn B; Heidenreich O; Chan LC; Yip SF; Krzywinski M; Eckert C; Möricke A; Schrappe M; Alonso CN; Schäfer BW; Krauter J; Lee DA; Zur Stadt U; Te Kronnie G; Sutton R; Izraeli S; Trakhtenbrot L; Lo Nigro L; Tsaur G; Fechina L; Szczepanski T; Strehl S; Ilencikova D; Molkentin M; Burmeister T; Dingermann T; Klingebiel T; Marschalek R
Leukemia; 2009 Aug; 23(8):1490-9. PubMed ID: 19262598
[TBL] [Abstract][Full Text] [Related]
9. A novel chromosomal inversion at 11q23 in infant acute myeloid leukemia fuses MLL to CALM, a gene that encodes a clathrin assembly protein.
Wechsler DS; Engstrom LD; Alexander BM; Motto DG; Roulston D
Genes Chromosomes Cancer; 2003 Jan; 36(1):26-36. PubMed ID: 12461747
[TBL] [Abstract][Full Text] [Related]
10. Panhandle PCR approaches to cloning MLL genomic breakpoint junctions and fusion transcript sequences.
Robinson BW; Felix CA
Methods Mol Biol; 2009; 538():85-114. PubMed ID: 19277575
[TBL] [Abstract][Full Text] [Related]
11. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia.
Super HG; Strissel PL; Sobulo OM; Burian D; Reshmi SC; Roe B; Zeleznik-Le NJ; Diaz MO; Rowley JD
Genes Chromosomes Cancer; 1997 Oct; 20(2):185-95. PubMed ID: 9331569
[TBL] [Abstract][Full Text] [Related]
12. Functional relevance of circRNA aberrant expression in pediatric acute leukemia with KMT2A::AFF1 fusion.
Tretti Parenzan C; Molin AD; Longo G; Gaffo E; Buratin A; Cani A; Boldrin E; Serafin V; Guglielmelli P; Vannucchi AM; Cazzaniga G; Biondi A; Locatelli F; Meyer LH; Buldini B; Te Kronnie G; Bresolin S; Bortoluzzi S
Blood Adv; 2024 Mar; 8(5):1305-1319. PubMed ID: 38029383
[TBL] [Abstract][Full Text] [Related]
13. The MLL recombinome of acute leukemias.
Meyer C; Schneider B; Jakob S; Strehl S; Attarbaschi A; Schnittger S; Schoch C; Jansen MW; van Dongen JJ; den Boer ML; Pieters R; Ennas MG; Angelucci E; Koehl U; Greil J; Griesinger F; Zur Stadt U; Eckert C; Szczepański T; Niggli FK; Schäfer BW; Kempski H; Brady HJ; Zuna J; Trka J; Nigro LL; Biondi A; Delabesse E; Macintyre E; Stanulla M; Schrappe M; Haas OA; Burmeister T; Dingermann T; Klingebiel T; Marschalek R
Leukemia; 2006 May; 20(5):777-84. PubMed ID: 16511515
[TBL] [Abstract][Full Text] [Related]
14. CRISPR Gene Editing of Murine Blood Stem and Progenitor Cells Induces MLL-AF9 Chromosomal Translocation and MLL-AF9 Leukaemogenesis.
Sarrou E; Richmond L; Carmody RJ; Gibson B; Keeshan K
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32549410
[TBL] [Abstract][Full Text] [Related]
15. CircR-looping the leukemic translocations: The cause of MLL translocations explained.
Chen M
Mol Cell; 2023 Jul; 83(13):2164-2166. PubMed ID: 37419090
[TBL] [Abstract][Full Text] [Related]
16. Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations.
Drexler HG; Quentmeier H; MacLeod RA
Leukemia; 2004 Feb; 18(2):227-32. PubMed ID: 14671638
[TBL] [Abstract][Full Text] [Related]
17. EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs.
Bindels EM; Havermans M; Lugthart S; Erpelinck C; Wocjtowicz E; Krivtsov AV; Rombouts E; Armstrong SA; Taskesen E; Haanstra JR; Beverloo HB; Döhner H; Hudson WA; Kersey JH; Delwel R; Kumar AR
Blood; 2012 Jun; 119(24):5838-49. PubMed ID: 22553314
[TBL] [Abstract][Full Text] [Related]
18. The YEATS domain epigenetic reader proteins ENL and AF9 and their therapeutic value in leukemia.
Hu H; Muntean AG
Exp Hematol; 2023 Aug; 124():15-21. PubMed ID: 37295550
[TBL] [Abstract][Full Text] [Related]
19. BCOR Binding to MLL-AF9 Is Essential for Leukemia via Altered EYA1, SIX, and MYC Activity.
Schmidt CR; Achille NJ; Kuntimaddi A; Boulton AM; Leach BI; Zhang S; Zeleznik-Le NJ; Bushweller JH
Blood Cancer Discov; 2020 Sep; 1(2):162-177. PubMed ID: 32954361
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic Role of Fusion-circRNAs Derived from Cancer-Associated Chromosomal Translocations.
Guarnerio J; Bezzi M; Jeong JC; Paffenholz SV; Berry K; Naldini MM; Lo-Coco F; Tay Y; Beck AH; Pandolfi PP
Cell; 2016 Apr; 165(2):289-302. PubMed ID: 27040497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
